Citation Impact
Citing Papers
Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease
2011
The Absence of Pericytes Does Not Increase the Sensitivity of Tumor Vasculature to Vascular Endothelial Growth Factor-A Blockade
2010
Cellular Source and Amount of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Tumors Determine Response to Angiogenesis Inhibitors
2009
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
2010
Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor
2008
Sustained VEGF Blockade Results in Microenvironmental Sequestration of VEGF by Tumors and Persistent VEGF Receptor-2 Activation
2008
Sequential Loss of Tumor Vessel Pericytes and Endothelial Cells after Inhibition of Platelet-Derived Growth Factor B by Selective Aptamer AX102
2007
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.
2001
Microenvironmental regulation of tumour angiogenesis
2017
Hallmarks of Cancer: The Next Generation
2011 Standout
Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling in Cancer Causes Loss of Endothelial Fenestrations, Regression of Tumor Vessels, and Appearance of Basement Membrane Ghosts
2004
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer
2006
Pathways mediating VEGF-independent tumor angiogenesis
2009
EGFR Antagonists in Cancer Treatment
2008 Standout
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
2007
Friends or foes — bipolar effects of the tumour stroma in cancer
2004
Axon Guidance Molecules in Vascular Patterning
2010
The cancer glycocalyx mechanically primes integrin-mediated growth and survival
2014 StandoutNatureNobel
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
2005 Standout
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Head and neck cancer
2008 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
Selective Reporting Biases in Cancer Prognostic Factor Studies
2005
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7
2007
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
2010 StandoutNature
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and Neck
2001
E6 and E7 Gene Silencing and Transformed Phenotype of Human Papillomavirus 16-Positive Oropharyngeal Cancer Cells
2009
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Oral Cancer Risk in Relation to Sexual History and Evidence of Human Papillomavirus Infection
1998
Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival
2003
Pericytes: gatekeepers in tumour cell metastasis?
2007
Sustained delivery of a HIF-1 antagonist for ocular neovascularization
2013 StandoutNobel
Cellular abnormalities of blood vessels as targets in cancer
2004
Mechanisms of disseminated cancer cell dormancy: an awakening field
2014
Inhibition of angiogenesis and invasion in malignant gliomas
2007
Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus
2004
Hallmarks of cancer: Interactions with the tumor stroma
2010
The serological response to papillomaviruses
1999
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy
2008 Standout
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Global cancer statistics
2011 Standout
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
2010 Nature
PDGF-C Mediates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment
2009
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Ubiquitin-dependent regulation of COPII coat size and function
2012 StandoutNatureNobel
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration
2016
Angiogenesis in life, disease and medicine
2005 StandoutNature
PDGF and Vessel Maturation
2009
Case–Control Study of Human Papillomavirus and Oropharyngeal Cancer
2007 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Invasion as limitation to anti-angiogenic glioma therapy
2003
Malignant Gliomas in Adults
2008 Standout
Changing patterns of tonsillar squamous cell carcinoma in the United States
2000
Capillary pericytes regulate cerebral blood flow in health and disease
2014 StandoutNature
Inhibition of Platelet-Derived Growth Factor B Signaling Enhances the Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Multiple Models of Ocular Neovascularization
2006
Emerging Biological Principles of Metastasis
2017 Standout
Angiogenesis with pericyte abnormalities in a transgenic model of prostate carcinoma
2005
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
2007
PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
2004
EMT: 2016
2016 Standout
The Extracellular Matrix of Blood Vessels
2009
Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
2008
Molecular basis for sunitinib efficacy and future clinical development
2007
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
2005
Inhibiting angiogenesis and tumorigenesis by a synthetic molecule that blocks binding of both VEGF and PDGF to their receptors
2005
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Pericytes and ocular diseases
2007
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
2010
Adenovirus-mediated HIF-1α gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection
2011 StandoutNobel
Antiangiogenic therapies for high-grade glioma
2009
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Predicting benefit from anti-angiogenic agents in malignancy
2006
Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale
2010
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity
2004
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Tumor Angiogenesis
2008 Standout
Pericytes and vessel maturation during tumor angiogenesis and metastasis
2010
Tumorigenesis and the angiogenic switch
2003 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Endothelial-Mural Cell Signaling in Vascular Development and Angiogenesis
2009
Inverse Relationship between Human Papillomavirus-16 Infection and Disruptivep53Gene Mutations in Squamous Cell Carcinoma of the Head and Neck
2008
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
2010
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
2001 Standout
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures
2009
Therapeutic Application of Noncytotoxic Molecular Targeted Therapy in Gliomas: Growth Factor Receptors and Angiogenesis Inhibitors
2008
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma
2013
Angiogenesis as a Therapeutic Target in Malignant Gliomas
2009
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Platelet-Derived Growth Factor Production by B16 Melanoma Cells Leads to Increased Pericyte Abundance in Tumors and an Associated Increase in Tumor Growth Rate
2004
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
2012 StandoutNobel
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
2005
Micrometastatic Disease and Metastatic Outgrowth: Clinical Issues and Experimental Approaches
2009
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
Pathological Neovascularization Is Reduced by Inactivation of ADAM17 in Endothelial Cells but Not in Pericytes
2010
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
2009
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
2009
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis.
2003
Endothelial Hypoxia-Inducible Factor-2α Is Required for the Maintenance of Airway Microvasculature
2019 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Eph Receptors and Ephrin Ligands: Important Players in Angiogenesis and Tumor Angiogenesis
2010
p53 Alterations Predict Tumor Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma: A Prospective Series
2000
Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin.
2003
Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.
2003
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer
2008
CNS pericytes: Concepts, misconceptions, and a way out
2009
A Multitargeted, Metronomic, and Maximum-Tolerated Dose “Chemo-Switch” Regimen is Antiangiogenic, Producing Objective Responses and Survival Benefit in a Mouse Model of Cancer
2004
Works of Ralf Erber being referenced
Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
2009
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
2006
Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas
2005
Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2
2002
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme
2004
TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer
1998
Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control.
1998
Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2
2002
Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries, determine vessel plasticity
2005
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival
2006
Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms
2003